Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 1;141(9):882-889.
doi: 10.1001/jamaophthalmol.2023.3315.

Three-Dimensional Structural Phenotype of the Optic Nerve Head as a Function of Glaucoma Severity

Affiliations

Three-Dimensional Structural Phenotype of the Optic Nerve Head as a Function of Glaucoma Severity

Fabian A Braeu et al. JAMA Ophthalmol. .

Abstract

Importance: The 3-dimensional (3-D) structural phenotype of glaucoma as a function of severity was thoroughly described and analyzed, enhancing understanding of its intricate pathology beyond current clinical knowledge.

Objective: To describe the 3-D structural differences in both connective and neural tissues of the optic nerve head (ONH) between different glaucoma stages using traditional and artificial intelligence-driven approaches.

Design, setting, and participants: This cross-sectional, clinic-based study recruited 541 Chinese individuals receiving standard clinical care at Singapore National Eye Centre, Singapore, and 112 White participants of a prospective observational study at Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania. The study was conducted from May 2022 to January 2023. All participants had their ONH imaged using spectral-domain optical coherence tomography and had their visual field assessed by standard automated perimetry.

Main outcomes and measures: (1) Clinician-defined 3-D structural parameters of the ONH and (2) 3-D structural landmarks identified by geometric deep learning that differentiated ONHs among 4 groups: no glaucoma, mild glaucoma (mean deviation [MD], ≥-6.00 dB), moderate glaucoma (MD, -6.01 to -12.00 dB), and advanced glaucoma (MD, <-12.00 dB).

Results: Study participants included 213 individuals without glaucoma (mean age, 63.4 years; 95% CI, 62.5-64.3 years; 126 females [59.2%]; 213 Chinese [100%] and 0 White individuals), 204 with mild glaucoma (mean age, 66.9 years; 95% CI, 66.0-67.8 years; 91 females [44.6%]; 178 Chinese [87.3%] and 26 White [12.7%] individuals), 118 with moderate glaucoma (mean age, 68.1 years; 95% CI, 66.8-69.4 years; 49 females [41.5%]; 97 Chinese [82.2%] and 21 White [17.8%] individuals), and 118 with advanced glaucoma (mean age, 68.5 years; 95% CI, 67.1-69.9 years; 43 females [36.4%]; 53 Chinese [44.9%] and 65 White [55.1%] individuals). The majority of ONH structural differences occurred in the early glaucoma stage, followed by a plateau effect in the later stages. Using a deep neural network, 3-D ONH structural differences were found to be present in both neural and connective tissues. Specifically, a mean of 57.4% (95% CI, 54.9%-59.9%, for no to mild glaucoma), 38.7% (95% CI, 36.9%-40.5%, for mild to moderate glaucoma), and 53.1 (95% CI, 50.8%-55.4%, for moderate to advanced glaucoma) of ONH landmarks that showed major structural differences were located in neural tissues with the remaining located in connective tissues.

Conclusions and relevance: This study uncovered complex 3-D structural differences of the ONH in both neural and connective tissues as a function of glaucoma severity. Future longitudinal studies should seek to establish a connection between specific 3-D ONH structural changes and fast visual field deterioration and aim to improve the early detection of patients with rapid visual field loss in routine clinical care.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Thiéry reported being a cofounder of the artificial intelligence start-up company Abyss Processing during the conduct of the study. Dr Girard reported grants from BrightFocus Foundation, SingHealth Duke-NUS, National Research Foundation Singapore, and National Medical Research Council Singapore and nonfinancial support from Abyss Processing, of which he is a cofounder, during the conduct of the study. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Summary of Statistical Analysis of 4 Automatically Extracted Sectorial Optic Nerve Head Parameters
A bracket marks each comparison where P < .05 as determined by a post hoc Tukey honestly significance difference test. Normal indicates the group with no glaucoma; participants with glaucoma were categorized into 1 of 3 severity groups based on the mean deviation (MD) of the 24-2 or 30-2 visual field: mild (MD, ≥−6.00 dB), moderate (MD, −6.01 to −12.00 dB), or advanced (MD, <−12.00 dB). I indicates inferior; IN, inferonasal; IT, inferotemporal; N, nasal; S, superior; SN, superonasal; ST, superotemporal; T, temporal.
Figure 2.
Figure 2.. Summary of Statistical Analysis of 4 Automatically Extracted Nonsectorial Optic Nerve Head Parameters
The horizontal line inside each box indicates the median value; upper and lower bound of each box, IQR; whiskers, range of values; circles, outliers. A bracket marks each comparison where P < .05 as determined by a post hoc Tukey honestly significance difference test. Normal indicates the group with no glaucoma; participants with glaucoma were categorized into 1 of 3 severity groups based on the mean deviation (MD) of the 24-2 or 30-2 visual field: mild (MD, ≥−6.00 dB), moderate (MD, −6.01 to −12.00 dB), or advanced (MD, <−12.00 dB).
Figure 3.
Figure 3.. Summary of Statistical Analysis of 2 Automatically Extracted Nonsectorial Optic Nerve Head Parameters
The horizontal line inside each box indicates the median value; upper and lower bound of each box, IQR; whiskers, range of values; circles, outliers. A bracket marks each comparison where P < .05 as determined by a post hoc Tukey honestly significance difference test. Normal indicates the group with no glaucoma; participants with glaucoma were categorized into 1 of 3 severity groups based on the mean deviation (MD) of the 24-2 or 30-2 visual field: mild (MD, ≥−6.00 dB), moderate (MD, −6.01 to −12.00 dB), or advanced (MD, <−12.00 dB).

Comment in

References

    1. Bussel II, Wollstein G, Schuman JS. OCT for glaucoma diagnosis, screening and detection of glaucoma progression. Br J Ophthalmol. 2014;98(Suppl 2)(suppl 2):ii15-ii19. doi:10.1136/bjophthalmol-2013-304326 - DOI - PMC - PubMed
    1. Robin TA, Müller A, Rait J, Keeffe JE, Taylor HR, Mukesh BN. Performance of community-based glaucoma screening using Frequency Doubling Technology and Heidelberg Retinal Tomography. Ophthalmic Epidemiol. 2005;12(3):167-178. doi:10.1080/09286580590969716 - DOI - PubMed
    1. Lavinsky F, Wollstein G, Tauber J, Schuman JS. The future of imaging in detecting glaucoma progression. Ophthalmology. 2017;124(12S):S76-S82. doi:10.1016/j.ophtha.2017.10.011 - DOI - PMC - PubMed
    1. Gonzalez-Hernandez M, Pablo LE, Armas-Dominguez K, de la Vega RR, Ferreras A, de la Rosa MG. Structure-function relationship depends on glaucoma severity. Br J Ophthalmol. 2009;93(9):1195-1199. doi:10.1136/bjo.2008.154815 - DOI - PubMed
    1. Medeiros FA, Zangwill LM, Bowd C, Mansouri K, Weinreb RN. The structure and function relationship in glaucoma: implications for detection of progression and measurement of rates of change. Invest Ophthalmol Vis Sci. 2012;53(11):6939-6946. doi:10.1167/iovs.12-10345 - DOI - PMC - PubMed

Publication types